£291.99

Springer Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Price data last checked 149 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£292 today · cheaper than every other day in the last 6 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 42 days • 42 data points (No recent data available)

Historical
Generating forecast...
£444.99 £276.69 £313.41 £350.13 £386.85 £423.57 £460.29 01 December 2025 11 December 2025 21 December 2025 31 December 2025 11 January 2026

Price Distribution

Price distribution over 42 days • 3 price levels

Days at Price
Current Price
1 day · current 24 days 17 days 0 6 12 18 24 £292 £348 £445 Days at Price

Price Analysis

Most common price: £348 (24 days, 57.1%)

Price range: £292 - £445

Price levels: 3 different prices over 42 days

Description

Malignant lymphomas remain a fascinating research topic for clinicians as well as basic scientists. Rapidly increasing technical sophistication, ex panded knowledge and broader implications of new findings underline the need for a forum to integrate the latest developments in the multiple areas involved in the challenging study of lymphoid malignancies. This volume includes contributions of renowned experts and is based on a selection of papers presented at the Second International Conference on Malignant Lymphomas that was held in Lugano, Switzerland, in June 1984. Updated information is provided on various experimental fields including cell biolo gy, immunology, genetics and cell biochemistry. Particular attention has been given to special clinical entities such as the lymphomas associated with the Acquired Immune Deficiency Syndrome. Recent advances in the treat of Hodgkin's disease, ncin-Hodgkin's lymphomas and childhood lym ment phomas are highlighted with emphasis on growing experience with new therapeutic approaches including monoclonal antibodies and bone marrow transplantation. The contents of the volume reflect and translate numerous avenues of exploration. While there might be some unavoidable overlap, most appear essentially complementary. The intent of the Program Committee of the Second International Conference on Malignant Lymphomas was to promote further interactions between all those who are devoting major efforts to elucidate the nature of these diseases or their optimal therapy. This volume will hopefully amplify this objective. The Editors wish to thank the contributors for delivering the manuscripts on schedule.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 January 1986
Listed Since
12 January 2007

Barcode

No barcode data available

Similar Products You Might Like

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
99% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£398.50 13 Jan 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
97% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£152.38 19 Dec 2025
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)
97% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)

Springer

£113.11 07 Jan 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
97% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.00 18 Apr 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
97% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£117.00 28 Feb 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
97% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£244.99 14 Jan 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
97% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£77.39 11 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
97% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 09 Mar 2026
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
97% match

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Springer

£57.70 19 Apr 2026
Aggressive Lymphomas (Hematologic Malignancies)
97% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£88.97 08 Mar 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
97% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£77.82 11 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
97% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 09 Mar 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
97% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.36 01 Mar 2026
Ioachim's Lymph Node Pathology
97% match

Ioachim's Lymph Node Pathology

Lippincott Williams & Wilkins

£147.80 17 Mar 2026
T-Cell Lymphomas (Contemporary Hematology)
97% match

T-Cell Lymphomas (Contemporary Hematology)

Humana

£79.93 23 Feb 2026
Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver
97% match

Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver

Springer

£73.57 01 Mar 2026
Skin Lymphoma: The Illustrated Guide
97% match

Skin Lymphoma: The Illustrated Guide

Wiley-Blackwell

£100.68 23 Jan 2026
Rare Lymphomas (Hematologic Malignancies)
97% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£109.04 19 Dec 2025
Lymphoproliferative Diseases of the Skin
97% match

Lymphoproliferative Diseases of the Skin

Springer

£88.10 22 Feb 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
97% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£179.99 08 Apr 2026
Mechanisms of B Cell Neoplasia 1998: Proceedings of the Workshop held at the Basel Institute for Immunology 4th–6th October 1998: 246 (Current Topics in Microbiology and Immunology, 246)
97% match

Mechanisms of B Cell Neoplasia 1998: Proceedings of the Workshop held at the Basel Institute for Immunology 4th–6th October 1998: 246 (Current Topics in Microbiology and Immunology, 246)

Springer

£113.02 07 Jan 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
96% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£69.58 07 Mar 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
96% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£65.04 28 Feb 2026
Atlas of Diagnostic Hematology
96% match

Atlas of Diagnostic Hematology

Elsevier

£153.14 13 Jan 2026